Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Lexaria Bioscience (LEXX) Assets Average (2016 - 2026)

Lexaria Bioscience's Assets Average history spans 11 years, with the latest figure at $6.3 million for Q1 2026.

  • Quarterly results put Assets Average at $6.3 million for Q1 2026, down 32.12% from a year ago — trailing twelve months through Feb 2026 was $6.3 million (down 32.12% YoY), and the annual figure for FY2025 was $6.5 million, up 9.13%.
  • Assets Average for Q1 2026 was $6.3 million at Lexaria Bioscience, up from $5.1 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $11.6 million in Q1 2022 to a low of $69909.0 in Q1 2024.
  • The 5-year median for Assets Average is $5.1 million (2025), against an average of $5.2 million.
  • The sharpest move saw Assets Average plummeted 95.66% in 2024, then skyrocketed 13110.99% in 2025.
  • Year by year, Assets Average stood at $4.0 million in 2022, then plummeted by 60.05% to $1.6 million in 2023, then skyrocketed by 490.51% to $9.3 million in 2024, then tumbled by 45.2% to $5.1 million in 2025, then increased by 22.61% to $6.3 million in 2026.
  • According to Business Quant data, Assets Average over the past three periods came in at $6.3 million, $5.1 million, and $5.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.